United States (US) Cell And Gene Therapy CDMO Market (2025-2031) | Share, Growth, Segmentation, Size & Revenue, Analysis, Value, Competitive Landscape, Industry, Outlook, Forecast, Companies, Trends

Name: United States (US) Cell And Gene Therapy CDMO Market (2025-2031) | Share & Growth
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Phase (Pre-clinical, Clinical), By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others) And Competitive Landscape

Product Code: ETC9962026	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Cell And Gene Therapy CDMO Market Outlook
Market Size of United States (US) Cell And Gene Therapy CDMO Market, 2024
Forecast of United States (US) Cell And Gene Therapy CDMO Market, 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Revenues & Volume for the Period 2021- 2031
United States (US) Cell And Gene Therapy CDMO Market Trend Evolution
United States (US) Cell And Gene Therapy CDMO Market Drivers and Challenges
United States (US) Cell And Gene Therapy CDMO Price Trends
United States (US) Cell And Gene Therapy CDMO Porter's Five Forces
United States (US) Cell And Gene Therapy CDMO Industry Life Cycle
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Phase for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Pre-clinical for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Clinical for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Product Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Gene Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Gene-Modified Cell Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Cell Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Indication for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Oncology for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Infectious Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Neurological disorders for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Rare Diseases for the Period 2021- 2031
Historical Data and Forecast of United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Cell And Gene Therapy CDMO Import Export Trade Statistics
Market Opportunity Assessment By Phase
Market Opportunity Assessment By Product Type
Market Opportunity Assessment By Indication
United States (US) Cell And Gene Therapy CDMO Top Companies Market Share
United States (US) Cell And Gene Therapy CDMO Competitive Benchmarking By Technical and Operational Parameters
United States (US) Cell And Gene Therapy CDMO Company Profiles
United States (US) Cell And Gene Therapy CDMO Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Cell And Gene Therapy CDMO Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Cell And Gene Therapy CDMO Market - Industry Life Cycle

3.4 United States (US) Cell And Gene Therapy CDMO Market - Porter's Five Forces

3.5 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Phase, 2021 & 2031F

3.6 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F

3.7 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume Share, By Indication, 2021 & 2031F

4 United States (US) Cell And Gene Therapy CDMO Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing investments in research and development in the field of cell and gene therapy

4.2.2 Growing prevalence of genetic disorders and chronic diseases driving demand for advanced therapies

4.2.3 Technological advancements leading to improved efficiency and cost-effectiveness in cell and gene therapy manufacturing

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and complex approval processes for cell and gene therapies

4.3.2 High initial investment and operational costs associated with setting up cell and gene therapy manufacturing facilities

4.3.3 Limited scalability and production capacity of current cell and gene therapy manufacturing processes

5 United States (US) Cell And Gene Therapy CDMO Market Trends

6 United States (US) Cell And Gene Therapy CDMO Market, By Types

6.1 United States (US) Cell And Gene Therapy CDMO Market, By Phase

6.1.1 Overview and Analysis

6.1.2 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Phase, 2021- 2031F

6.1.3 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Pre-clinical, 2021- 2031F

6.1.4 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Clinical, 2021- 2031F

6.2 United States (US) Cell And Gene Therapy CDMO Market, By Product Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene Therapy, 2021- 2031F

6.2.3 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Gene-Modified Cell Therapy, 2021- 2031F

6.2.4 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy, 2021- 2031F

6.3 United States (US) Cell And Gene Therapy CDMO Market, By Indication

6.3.1 Overview and Analysis

6.3.2 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Oncology, 2021- 2031F

6.3.3 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Infectious Diseases, 2021- 2031F

6.3.4 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Neurological disorders, 2021- 2031F

6.3.5 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Rare Diseases, 2021- 2031F

6.3.6 United States (US) Cell And Gene Therapy CDMO Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Cell And Gene Therapy CDMO Market Import-Export Trade Statistics

7.1 United States (US) Cell And Gene Therapy CDMO Market Export to Major Countries

7.2 United States (US) Cell And Gene Therapy CDMO Market Imports from Major Countries

8 United States (US) Cell And Gene Therapy CDMO Market Key Performance Indicators

8.1 Number of clinical trials utilizing cell and gene therapies in the US

8.2 Adoption rate of automated manufacturing technologies in cell and gene therapy production

8.3 Percentage increase in partnerships and collaborations between CDMOs and biopharmaceutical companies for cell and gene therapy manufacturing

9 United States (US) Cell And Gene Therapy CDMO Market - Opportunity Assessment

9.1 United States (US) Cell And Gene Therapy CDMO Market Opportunity Assessment, By Phase, 2021 & 2031F

9.2 United States (US) Cell And Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F

9.3 United States (US) Cell And Gene Therapy CDMO Market Opportunity Assessment, By Indication, 2021 & 2031F

10 United States (US) Cell And Gene Therapy CDMO Market - Competitive Landscape

10.1 United States (US) Cell And Gene Therapy CDMO Market Revenue Share, By Companies, 2024

10.2 United States (US) Cell And Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Cell And Gene Therapy CDMO Market

Eritrea Cell And Gene Therapy CDMO Market

Ethiopia Cell And Gene Therapy CDMO Market

Fiji Cell And Gene Therapy CDMO Market

Finland Cell And Gene Therapy CDMO Market

Gabon Cell And Gene Therapy CDMO Market

Global Cell And Gene Therapy CDMO Market

Middle East Cell And Gene Therapy CDMO Market

North America Cell And Gene Therapy CDMO Market

Export potential assessment - trade Analytics for 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here